Elicio Therapeutics, Inc. (ELTX) Revenue Growth
Elicio Therapeutics, Inc. (ELTX) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2022-12-31 | -91.63% |
| 2023-12-31 | N/A |
| 2024-12-31 | N/A |
| 2025-12-31 | N/A |
How ELTX compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| PLSE | Pulse Biosciences Inc | -50.63% |
| INO | Inovio Pharmaceuticals Inc. | -69.99% |
| ALLO | Allogene Therapeutics Inc. | -76.84% |
| XBIT | XBiotech Inc. | -78.20% |
| ALEC | Alector Inc. | -79.07% |
These are five companies in the same sector as ELTX with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Elicio Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("ELTX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ELTX | $2.41 | -3.60% | 0.49M |
| 3 | ||||
| 4 | ||||
| 5 |